Ticker Details
Embecta Corp.
IPO Date:	April 1, 2022
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$296.33M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 2.45%
Avg Daily Range (30 D):	$0.13 | 3.42%
Avg Daily Range (90 D):	$0.18 | 3.47%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	1.31M
Avg Daily Volume (90 D):	1.79M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	106
Avg Trade Size (Sh.) (90 D):	120

Institutional Trades
Total Institutional Trades:	1,617
Avg Institutional Trade:	$2.15M
Avg Institutional Trade (30 D):	$1.03M
Avg Institutional Trade (90 D):	$1.35M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.31M
Avg Closing Trade (30 D):	$1.07M
Avg Closing Trade (90 D):	$1.44M
Avg Closing Volume:	139.89K

News

Aug 10, 2026 @ 1:47 PM EMBC Investors Have Opportunity to Lead Embecta Co... Source: Schall, Brown & Schwartz Llp

Aug 7, 2026 @ 6:52 PM ZILLOW DEADLINE: ROSEN, THE FIRST FILING FIRM, Enc... Source: Rosen Law Firm

Aug 7, 2026 @ 10:30 AM Embecta Corp. Reports Third Quarter Fiscal 2026 Fi... Source: Unknown

Aug 7, 2026 @ 10:00 AM embecta Announces Quarterly Cash Dividend Source: Na

Aug 6, 2026 @ 2:31 AM EMBC 12-DAY DEADLINE ALERT: Embecta Corp. Investor... Source: Hagens Berman

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$1.5	$.36	$-.07
Diluted EPS	$1.47	$.36	$-.07
Revenue	$1.02B	$271.7M	$221.8M
Gross Profit	$601.3M	$153.3M	$127.8M
Net Income / Loss	$87.5M	$21.1M	$-4.1M
Operating Income / Loss	$223.5M	$48.7M	$35M
Cost of Revenue	$417.4M	$118.4M	$94M
Net Cash Flow	$-16M	$24.7M	$-10.9M
PE Ratio